Related Experiment Video
Updated: Dec 20, 2025
08:33
Author Spotlight: An Optimized Automated Method for Investigating Retinoic Acid Receptors in Neuronal Mitochondria
Published on: July 28, 2023
878
Proteomic profiling reveals mitochondrial alterations in Rett syndrome
Vittoria Cicaloni1, Alessandra Pecorelli2, Laura Tinti1
1Toscana Life Science Foundation, Via Fiorentina 1, 53100, Siena, Italy.
Free Radical Biology & Medicine
|May 24, 2020
Summary
Rett syndrome (RTT), a neurodevelopmental disorder, involves mitochondrial dysfunction. This study reveals proteomic changes in mitochondrial proteins, confirming their role in RTT pathogenesis.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Rett syndrome (RTT) is a neurodevelopmental disorder linked to MECP2 gene mutations.
- Metabolic dysfunction, particularly oxinflammation and mitochondrial issues, is increasingly recognized in RTT.
- Proteomic data supporting these RTT cellular changes are limited.
Purpose of the Study:
- To comprehensively characterize the RTT cellular proteome using large-scale proteomics.
- To investigate the role of mitochondrial dysfunction in RTT pathogenesis.
- To identify specific protein expression changes in RTT fibroblasts.
Main Methods:
- Proteomic analysis of primary dermal fibroblasts from RTT patients and controls.
- Data mining approaches to analyze proteomic data.
- Assessment of mitochondrial morphology, dynamics, and mitophagy.
Main Results:
- First comprehensive characterization of the RTT cellular proteome.
- Significant changes in proteins associated with the mitochondrial network.
- Altered expression of mediators of mitochondrial dynamics and mitophagy.
- Abnormal mitochondrial morphology observed in RTT fibroblasts.
Conclusions:
- Proteomic analysis confirms the critical role of mitochondrial dysfunction in RTT.
- Mitochondrial network alterations are a key feature of RTT pathophysiology.
- These findings provide a deeper understanding of RTT pathogenesis and progression.
